News
TAMPA, FL / ACCESS Newswire / July 29, 2025 / The explosive popularity of GLP-1 weight-loss medications such as Ozempic®, ...
TAMPA, FL / ACCESS Newswire / July 29, 2025 / The explosive popularity of GLP-1 weight-loss medications such as Ozempic®, ...
Diabetes drugs from Eli Lilly and Novo Nordisk, such as Mounjaro, Zepbound, Ozempic, and Wegovy, are expanding beyond ...
Strong efficacy and cardiovascular benefits should allow Novo to continue growing sales of GLP-1 therapies in diabetes. Ozempic and Rybelsus helped Novo gain share over Eli Lilly's once-weekly ...
11h
Fashionista on MSN'GLP-1 Beauty' Is Here — But Is it a Marketing Gimmick?
As consumers drop pounds, beauty and wellness brands are dropping products in hopes of cashing in on the rise of weight-loss drugs.
11h
Barchart on MSNHere’s What Happened the Last Time Novo Nordisk Stock Was This Oversold
Novo Nordisk (NVO) is on pace to gap lower at the opening bell today, with shares of the pharma giant plunging up to 30% in ...
President Trump said yesterday that there was “real starvation” in Gaza, disagreeing with a recent assertion by Israel’s ...
The pharma giant cut its guidance and named a new CEO, hoping to revive growth. Its stock fell as much as 30%, wiping almost $93 billion from its market value.
Stock markets were mixed on Tuesday as investors started turning their attention from trade deals to a slew of company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results